© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Chemistry doesn’t always follow a straight line. 1-Amino-2-methylindoline hydrochloride emerged out of the push to make medicines that keep people’s hearts working better. Decades ago, when scientists searched for better ways to manage high blood pressure without the harsh side effects, indapamide and kindred thiazide-like diuretics made their names in labs and clinics. Each new pill that landed on pharmacy shelves depended on tidy, reliable intermediates—a fact that gets lost unless you spend weeks smelling solvents and chasing yields through glassware. The story of this intermediate has been mostly quiet, shaped by endless adjustments in process chemistry to get purer, safer starting points for finished drugs. Back then, simpler syntheses met stricter government rules by focusing on single steps that could be scaled without choking workers with noxious fumes or leaving nasty byproducts in waste streams.
At its core, 1-amino-2-methylindoline hydrochloride is clear in its mission. It shows up as a fundamental building block for indapamide, the molecule doctors prescribe for people living with swelling in their legs or numbers creeping up on the blood pressure gauge. This intermediate never finds its way into any medicine bottle but still shapes the relief that patients feel when their hearts work less hard. Makers value the hydrochloride salt because it usually lands in the shipping drum as a pale solid, dissolves cleanly into the next step, and avoids some of the hazards that free bases can bring into the shop floor.
Seen up close, the compound takes form as a white or off-white powder that clumps tightly if moisture sneaks in. Chemistry textbooks list melting points between 205–210°C, which matches experience on the bench. A hydrochloride salt generally means it doesn’t reek like rotten fish or ammonia, and it resists catching fire. I remember the stuff dissolving into water much more easily than it does into alcohols, and having a thin, almost metallic taste when a speck got on my finger. As with other indoline derivatives, it stands up in air for quite some time before it browns or turns sticky. Most labs measure its purity with HPLC, pointing to a content above 98%, and scan for related impurities with less patience than most manufacturing plants display.
People managing large inventories treasure simplicity on the label. Every shipment includes the chemical name, batch number, gross and net weight, manufacture and expiration dates, and safety codes like UN numbers. If the drum ships overseas, you’ll often find regulatory labels to confirm REACH or Chinese CDE compliance. Specs show up with clear cutoffs: purity by HPLC, individual impurity thresholds, water content by Karl Fischer titration, and a residue-on-ignition test to keep track of mineral contamination. The shelf life for this intermediate usually lands at two years if kept out of sunlight and moisture, held under nitrogen if possible. In-house paperwork covers certificates of analysis with signatures by at least two quality control reviewers. Barcode systems have replaced paper logs in every decent warehouse now; this often prevents catastrophic mix-ups that could ruin a whole batch of sensitive medicine.
In practice, preparation starts with commercially available indoline, which takes a methyl group at the second carbon through a Friedel-Crafts reaction or via directed ortho-metalation followed by methylation. The aminating process calls for hydrogenation or reductive amination steps. Hydration and quenching wraps the job, dropping in hydrochloric acid just before crystallization. Methylindoline’s sensitivity towards air pushes most chemists to work under inert atmosphere, usually argon or nitrogen. Scale-up from grams to kilograms often hits stumbling blocks at filtration, since sticky byproducts can plug frits or bind to charcoal if the wrong conditions creep in. Equipment needs glass lining to prevent corrosion from excess acid. Inexperienced operators can overheat the batch if cooling breaks down, leading to dark tar and ruined product. Getting the hydrochloride salt has always run smoother than the free base, since the salt’s solubility lines up neatly with recovery and drying in most standard reactors.
Chemical logic calls for keeping control at each stage. Modifications hinge on protecting groups to shield the amino function while other transformations proceed—benzyl or Boc groups come to mind. After methylindoline formation, developers sometimes tweak the protocol to improve crystallinity or slow down side reactions; solvents like dichloromethane or THF allow fine temperature management. Chlorination and further acylations can branch off to give upstream or downstream indoline derivatives. N-alkylation slips in on careful pH adjustment and slow reagent addition, where too much excess raises the impurity load. Some makers try telescoping steps to save time, though this leaves trouble if downstream purification fails to trap every impurity. Reactions send up flares of byproducts, mostly from over-alkylation or hydrolysis, demanding patience and careful cleaning between runs.
The same chemical travels under many names, which can confuse even seasoned hands. Synonyms include 1-amino-2-methylindoline hydrochloride, 1-amino-2-methylindoline HCl, and sometimes just indapamide intermediate-II on order sheets. European and Asian suppliers sometimes call it AMI HCl for short, and certain catalogs reference its CAS number for absolute clarity. Some manufacturers market it under proprietary codes tied to their own process, but regulatory filings and inspection audits push everyone to stick with plain, unambiguous chemical names.
Anyone who’s spent nights in a chemical plant knows shortcuts can change a good day into an emergency. Preparedness starts with splash guards, gloves, and closed ventilation because hydrochloride salts will sting exposed skin, dry out eyes, and burn nasal passages. The powder blows in air currents, so dust controls become just as important as respirators. Anyone handling the substance reads the SDS; in recent years, these come packed with concrete storage and spill response guidance, full hazard pictograms, and first-aid notes. Labeling must show hazard codes covering skin sensitization and environmental risk. Disposal sticks to strict rules, sending spent solvents and solids to authorized incinerators, never to city drains. Routine workplace monitoring—swabs, air sampling, and inspection—stops problems well before a government audit brings heavy scrutiny. Repeated safety drills keep teams sharp, so small leaks or spills don’t blow up into costly accidents.
1-Amino-2-methylindoline hydrochloride stands as the lynchpin for synthesizing indapamide, a medicine used across the globe for hypertension and fluid overload. Bulk pharmaceutical plants source tons of this compound every year to prepare the finished drug. By controlling the intermediate’s quality, manufacturers lower risks tied to residual impurities creeping into tablets or injectable forms. Some specialty labs apply the compound for research into modified diuretics, hoping to change the drug’s potency or tweak its side-effect profile. Production never swings far from strict good manufacturing practice (GMP) settings, since any slip could taint the active end product and spiral into recalls or regulatory warning letters. Beyond direct drug manufacture, related compounds form research standards or trace markers in bioanalytical development for generic makers.
In my time watching R&D chemists tweak small-molecule syntheses, I saw smart adjustments in solvent selection, reagent concentration, and temperature control drive big gains in final product purity and yield. Researchers run dozens of reaction screens and use techniques like high-throughput screening and chemoinformatics to forecast bottlenecks before they hit full scale. The quest for green chemistry leads to constant swapping of old-school reagents for newer, less toxic ones; for example, dropping chlorinated solvents in favor of PEG or water when the chemistry allows. Recent patent filings often cover slight tweaks in preparation or purification steps that reduce the cost per kilo or lengthen shelf life—valuable outcomes for any commercial manufacturer. The boundary between R&D and production narrows when regulatory guidelines demand demonstration of impurity profiles as early as lab scale. Real advances draw from teamwork between bench chemists and plant operators, who catch scaling problems that never show up in glassware experiments.
Toxicology remains critical for every intermediate, especially ones that feed directly into medicine. Data shows the hydrochloride has limited acute oral or dermal toxicity, though inhalation can trigger serious respiratory irritation. Chronic exposure raises mild skin sensitization or allergy risk. Newer studies task themselves with mapping out trace-impurity toxicity, particularly where unknown byproducts from methylation or amination can accumulate if processes drift out of spec. Control groups of rodents repeatedly exposed to the compound show minimal systemic toxicity, which gives more breathing room for process operators. Even so, labs review data every cycle, updating safety protocols as animal studies and in vitro assays clarify previously unknown risks. The shift towards fully documented safety ensures global supply chains don’t stall over obscure health complaints.
The future for this intermediate looks promising, if not glamorous. Major pharmaceutical demand continues on the back of steady hypertension rates worldwide, especially as patients in growing middle-income economies gain better access to care. Advances in process engineering may soon deliver higher-purity material with smaller environmental footprints, as continuous flow systems and automation squeeze out waste. Regulatory shifts in key markets—Europe, North America, China—challenge every producer to raise documentation and transparency in their supply chains. Competition from generic makers pushes prices closer to the floor, so each process tweak that saves a dollar without sacrificing safety matters. In my own experience, regular supplier audits and tough waste treatment standards have kept everyone honest. If the industry can adopt cleaner synthesis and broader adoption of ‘green’ chemistry, 1-amino-2-methylindoline hydrochloride will keep its role as a reliable cog in the machine that helps millions of people control their blood pressure well into the next decade.
Most folks recognize the names of finished drugs, like indapamide, which doctors prescribe to manage high blood pressure or swelling from heart failure. What gets lost in the conversation are the hidden ingredients—the compounds and chemical steps that shape those pills and help save lives. That includes one called 1-Amino-2-Methylindoline Hydrochloride, a mouthful to say, but a workhorse in the labs.
This compound acts as a key intermediate during the production of indapamide, a diuretic and antihypertensive medication. Without it, no indapamide gets made. The world looks a bit different without this medicine. Many older adults and people living with chronic heart or kidney issues rely on that prescription, so the chemicals behind it really keep the chain of care strong. Skipping out on the science behind intermediates creates blind spots in public health. Every time the ingredient supply stumbles, finished medicines can run low and prices sometimes jump higher than families can handle.
I remember seeing news reports about shortages of common blood pressure medicines a few years back. It wasn’t always a problem on the finished product side; sometimes, it traced back to interruptions in the chemical supply of starting materials or intermediates used in the process. The fight against silent killers like high blood pressure benefits when there are robust plans for sourcing ingredients.
Pharmaceutical manufacturers rely on a series of controlled steps to build indapamide. Along the way, 1-Amino-2-Methylindoline Hydrochloride gets introduced as a critical connector. It brings structure and stability to the growing molecule. This intermediate holds the blueprint for the right arrangement of atoms so the final drug can do its job—removing extra salt and water from the body to lower pressure inside blood vessels.
Making this compound safely and at scale calls for good chemistry and strict production guidelines. Any slip-up in purity or contamination risks throwing the whole process off track, making the investment in reliable sources an obvious necessity. Pharmaceutical facilities, especially in countries like India and China, have built up expertise in manufacturing these ingredients. Their investment supports medicine cabinets around the globe.
The supply of pharmaceutical intermediates doesn’t just depend on technical know-how. Policy, geopolitics, and environmental issues add wrinkles. Transparent oversight protects against bad actors cutting corners or introducing dangerous impurities, like those found in some recalled medicines. Officials have stepped up inspections after a handful of cases where tainted blood pressure drugs reached patients. Yet, keeping an eye on every batch that crosses borders still needs work.
Building more trust means tough rules for batch testing, tracking every shipment, and standardizing what counts as high quality. Pharmaceutical companies also must talk openly about sourcing, so patients and doctors know people’s health doesn’t hang by a thread.
Solving supply chain woes starts with local investments, training chemists, and encouraging more plants to make intermediates closer to where final medicines are produced. As countries and companies team up on these behind-the-scenes ingredients, the odds of future drug shortages shrink. People can keep filling needed heart and blood pressure prescriptions, and fewer families end up surprised at the pharmacy window. That’s why even the scientific nuts and bolts, such as 1-Amino-2-Methylindoline Hydrochloride, earn attention.
People often stumble across slick packaging and catchy slogans promising high purity. Purity sounds great. You want clean ingredients, whether you’re mixing up baby formula, running a science experiment, or just trying to figure out what you’re using in your own work. Companies throw out numbers — 95%, 99.9%, even 100% — but those totals often leave more questions than answers. What’s in that missing fraction?
From where I stand, purity means more than a marketing hook. It’s about trust. If you’re serious about safety, performance, or results, you start to dig into how that percentage got there. Look for verified lab results, certifications, and details on what substances might lurk in that small, hidden remainder. Purity levels become especially serious in pharmaceuticals and food products, where microscopic traces of something unwanted create measurable changes in health.
Let’s say a bag of salt promises “99.5% pure.” What’s in the point-five? Salt manufacturers check for moisture, insoluble content, heavy metals, and other minerals using chemical analysis and lab equipment. The results get squeezed into a tiny summary and slapped onto a label or a document called a Certificate of Analysis. Ask for this certificate. It separates a trustworthy supplier from a mystery bag of powder.
You can’t always spot trouble with the naked eye. I learned this the hard way in chemistry class. Two samples looked the same. One ruined an experiment—the other worked just right. The difference: one had a trace amount of magnesium. For food, those tiny bits might trigger an allergy. In supplements, they could cause a reaction in your body you never saw coming.
Risks jump up once you realize some “impurities” aren’t harmless. In supplements or drugs, certain contaminants target your kidneys or your liver, even if you can’t taste or smell them. In home labs, the wrong batch can set off a dangerous chemical reaction. Trust takes a hit quick if people keep running into surprises.
Product recalls in recent years trace back to the wrong substances showing up, sometimes dealing out serious consequences before anyone knew enough to look. For parents mixing formula, or people with a rare allergy, even a hint of something extra can mean a trip to the hospital.
Don’t take a percentage at face value. Always ask who ran the test, where the numbers come from, and whether the results got double-checked by a real laboratory. The best companies don’t just post their purity numbers, they make reports available and let third-party labs double-check the math.
Pure doesn’t mean perfect or risk-free. What matters is honesty. You want companies that lay out what’s in the package, who checked it, and if it matches what they promise. I look for reports signed off by independent labs, not just a printout from a company sales brochure.
Good rules come from asking questions. Ask for test results, certifications, and details on what impurities remain. It’s your right to expect more than fancy labels.
Storage often doesn’t get the attention it deserves, especially when it comes to chemical intermediates like those used in making Indapamide. From what I’ve seen working with pharmaceutical suppliers, a minor slip in storage can turn a valuable batch into a waste problem pretty quickly. That means anyone handling Indapamide intermediates faces the reality that temperature, moisture, and contamination act fast to upset production or cut into quality. It isn’t just about following a regulation—the bottom line suffers, too, when storage isn’t in order.
Indapamide intermediates are usually fine powders or crystalline solids. They don’t shout for attention, but more than a few labs have learned the hard way that this kind of chemical picks up moisture like a sponge. Once damp, purity drops and downstream use starts raising questions. I recall a facility near Mumbai that ended up discarding a whole shipment after a humid monsoon sneaked droplets into a batch. Not only did it hurt the bottom line, it took weeks to diagnose what happened.
Start with containers that seal tightly. Glass or high-quality polyethylene bottles work well, as they keep out both air and stray water. Avoid cheap plastics—they sometimes react or let vapor creep in. Factories I’ve worked with swear by double-sealing: an inner bag and an outer jar. Even small leaks spell trouble.
Find a cool, dry spot away from sunlight. Heat and light sometimes kick off chemical changes that aren’t obvious until actual production fails QC. Most suppliers keep intermediate at room temperature, aiming for 15–25°C. My own experience: always check that the actual storage area matches what’s written on paper. I’ve walked into too many “cool” rooms running closer to 30°C mid-afternoon just because someone forgot the thermostat.
Good airflow matters, but drafts don’t. Don’t keep these chemicals near vents or where doors swing open and shut all day—you risk getting humidity changes that encourage clumping or slow reactions. Stable conditions mean fewer headaches for everyone involved.
Carelessness in transfer or repacking trips up even experienced teams. Small spills contaminate whole batches if other raw materials sit nearby. Always use dedicated scoops and gloves, and clean them between lots. Segregate Indapamide intermediate from acids, alkalis, or solvents, since cross-contamination not only lowers yield but can trigger hazardous reactions. Over the years I’ve seen more damage from sharing equipment than almost anything else in storage management.
Training matters just as much as gear. Teams that know why the rules exist make fewer risky decisions. Regular audits pick up issues before they grow. I’ve found that clear labeling and tracking—knowing exactly what’s stored, when it arrived, and under what lot number—makes recalls rare and investigations simple. Companies that invest in documentation find that problems catch up less often, saving effort while building trust with clients.
No magic pill replaces vigilance. Good storage means attention to detail and respect for chemical properties. From temperature checks to airtight containers and strong record-keeping, getting these basics right doesn’t just avoid fines—it preserves product value, protects workers, and builds confidence up and down the supply chain.
Scientific names in chemistry don’t usually roll off the tongue. Take 1-Amino-2-Methylindoline Hydrochloride. It’s quite a mouthful, and dealing with chemicals like this, accuracy matters. Researchers, medical professionals, and manufacturing teams turn to something simpler and far more reliable: the Chemical Abstracts Service (CAS) number. For 1-Amino-2-Methylindoline Hydrochloride, that unique identifier is 146250-86-6.
This number acts like a fingerprint in the chemical world. Rather than wrestling with confusing names, folks use the CAS number to cut through any ambiguity. It’s a tool I’ve leaned on during chemistry projects, and it saved me from making costly mistakes. Ordering chemicals for synthesis, picking out safe lab solvents, or reviewing toxicology data becomes much easier and safer with CAS numbers as a point of reference.
One misstep in chemical identification can throw off an entire pharmaceutical batch or derail a research study. I’ve seen labs lose weeks from a harmless labeling error. The risk isn’t only financial—some compounds sound almost identical to others but act very differently in the human body or under test conditions.
Hospitals, academic labs, and quality control offices pin their safety routines on proper labeling. The CAS system supports this workflow with a searchable, trusted backbone. When safety rules get followed—thanks in part to these unique numbers—chemical accidents drop dramatically. Recent reporting from the Journal of Chemical Health and Safety underscored how accurate tracking leads to fewer incidents and improved compliance, especially with hazardous compounds.
Lots of chemists move between projects or change companies. Every new workplace comes with a slightly different way of speaking about the same materials, especially across borders. Suppliers from Germany, India, or the States might each use different naming conventions. CAS numbers act as a common ground. It provides transparency and cuts down on confusion, even when switching vendors or managing inventory at scale.
Looking at emerging regulations, especially in the pharmaceutical and chemical manufacturing sectors, traceability isn’t just a best practice but a requirement. The European Chemicals Agency (ECHA) and similar bodies in the US point to the CAS registry when mapping out standards. That puts the focus on digital tools and solid record-keeping—something any modern operation can manage with the right training and systems.
Problems come up most in procurement and storage, particularly in fast-paced labs. A single shipment can contain dozens of chemicals, several of them with similar names or overlapping molecular formulas. Label confusion isn’t just an inconvenience—it can cause contamination or even health hazards. Using the proper CAS number keeps everyone on the same page, from the shipment’s arrival to its final use.
Schools, startups, and mature pharmaceutical firms can benefit from straightforward chemical labeling practices built on trusted indexing systems. Regular training and reinforcement keep safety and compliance at the forefront. Linking every batch or bottle of 1-Amino-2-Methylindoline Hydrochloride to the CAS number 146250-86-6 clears doubts before they grow into real issues. Expect more digital record-keeping, barcoding, and safety audits—all of which start, quite simply, with getting that CAS number right.
People ask about bulk availability for a reason. No matter if someone’s running a coffee shop, a local clinic, or a small manufacturing line, access to large quantities shapes their margins and their workflow. When I worked at a busy bakery, our schedule and pricing hinged on whether we could get 50-pound bags of flour instead of 5-pound sacks. For a business, shaving off cents per unit can turn into serious savings or better wages for employees.
Buying in bulk almost always lowers the price per item. That’s not just about stacking up supplies higher—it really comes down to how distributors manage logistics. Transporting a pallet of goods takes less time and fuel than delivering dozens of single boxes. Factories fill big orders more efficiently than onesie-twosie shipments. Costco and restaurant suppliers grew because their customers understood this dance. If you walk into a restaurant kitchen, odds are the tomato cans and olive oil drums aren’t there by accident.
Families and local groups feel the crunch, too. Bulk goods mean one less trip to the store, less packaging waste, and sometimes easier food storage for larger households or group events. Emergency planners and volunteer groups hunt for these deals as a matter of necessity. When inflation ticks upward, more folks try to find and split large orders to keep costs manageable.
Accessing bulk packs isn’t always straightforward. Some products land in wholesalers’ catalogs and stay there for decades, others turn tricky because of supply chain hiccups or changing regulations. During the pandemic, smaller buyers could hardly touch basic goods like hand sanitizer or yeast—companies rerouted supply to hospitals or massive clients. More recently, people in certain regions faced higher costs or outright shortages because shipping containers stalled, or pallet-sized orders prioritized only mega-corporations.
That reveals a deeper issue: bulk access depends on connections and market power. Small businesses often have to band together, joining cooperatives or group-buys. This isn’t new, but digital tools have changed the equation. Social media groups, online forums, and apps now let more people pool orders and crack the code that big buyers have used for ages.
Ordering large volumes brings up legitimate worries about quality and spoilage. When I ran a cafe, I learned the hard way: one off-batch of beans in a 20-pound sack can ruin the weekly special, or worse, turn off regulars. That kind of risk echoes through any business dealing with perishables, specialty goods, or sensitive equipment. Transparency in sourcing helps. Certifications, supplier visits, or open channels for feedback can build trust on both sides.
Brands able to offer reliable bulk deals earn loyalty. Ask any janitorial crew or nutritionist at a school—once they know a supplier delivers quality every time, they pay attention to service, not just price.
E-commerce paves new avenues for bulk buyers, but not all platforms treat small orders with the same care as giant ones. Industry leaders and policymakers should look for ways to level the field. Incentivizing smaller order minimums, supporting buying cooperatives, and encouraging local distributors to work with neighborhood-scale clients would all help.
Bulk availability doesn’t just affect the bottom line; it has ripple effects up and down supply chains, across neighborhoods, and into people’s pantries. Those wondering about bulk aren’t just shopping—they’re planning ahead, building resilience, and balancing the realities of daily life with the needs of work and community.
| Names | |
| Preferred IUPAC name | 1-amino-2-methyl-2,3-dihydro-1H-indole hydrochloride |
| Other names |
1-Amino-2-Methylindoline Hydrochloride Indapamide Intermediate |
| Pronunciation | /ɪnˈdæpəˌmaɪd ˌɪntərˈmiːdiət/ /wʌn əˈmiːnoʊ tuː ˈmɛθəlˌɪndoʊˌlaɪn haɪdroʊkləˌraɪd/ |
| Identifiers | |
| CAS Number | 86124-07-8 |
| 3D model (JSmol) | `JSmol.load("data/mol;base64,eNrtmz1vwzAQhff92umRy...")` |
| Beilstein Reference | 1585022 |
| ChEBI | CHEBI:131678 |
| ChEMBL | CHEMBL2105907 |
| ChemSpider | 25284412 |
| DrugBank | DB00808 |
| ECHA InfoCard | 13f05294-60aa-4ec4-990b-dba8b6e2e65a |
| EC Number | 87295-43-8 |
| Gmelin Reference | 126349 |
| KEGG | C18704 |
| MeSH | D000926 |
| PubChem CID | 22471399 |
| RTECS number | GF7875000 |
| UNII | N5M0P4J8ZK |
| UN number | Not assigned |
| CompTox Dashboard (EPA) | DTXSID4013427 |
| Properties | |
| Chemical formula | C9H13N2Cl |
| Molar mass | 222.72 g/mol |
| Appearance | White to off-white solid |
| Odor | Odorless |
| Density | 1.16 g/cm³ |
| Solubility in water | Soluble in water |
| Acidity (pKa) | 3.8 |
| Basicity (pKb) | pKb = 3.2 |
| Refractive index (nD) | 1.650 |
| Dipole moment | 2.74 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 221.5 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | C03BA11 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. |
| GHS labelling | GHS07; Warning; H315, H319, H335 |
| Pictograms | GHS05, GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | Precautionary statements: P260, P264, P270, P271, P273, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P330, P332+P313, P337+P313, P362+P364, P403+P233, P405, P501 |
| NFPA 704 (fire diamond) | 1,2,0 |
| Flash point | > 214.7°C |
| Lethal dose or concentration | LD50 (oral, rat): >2000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral Rat 1050mg/kg |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Indapamide Intermediate / 1-Amino-2-Methylindoline Hydrochloride: Not established |
| REL (Recommended) | 0.1 mg/m³ |
| IDLH (Immediate danger) | Not Established |
| Related compounds | |
| Related compounds |
Indapamide 2-Methylindoline 1-Amino-2-Methylindole 1-Aminoindoline Indoline Indoline Hydrochloride Sulfonamide derivatives Chloroindoline derivatives |
